| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011266A2 Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein |
| 04/18/1996 | WO1996011259A1 TGF-β1, ACTIVIN RECEPTORS 1 AND 3 |
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011213A1 Dimeric il-4 inhibitors |
| 04/18/1996 | WO1996011211A1 Selective inhibition of internally initiated rna translation |
| 04/18/1996 | WO1996011210A1 Cyclic hexapeptides having antibiotic activity |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996011208A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/18/1996 | WO1996011207A1 Compositions and methods for interfering with hepatitis b virus infection |
| 04/18/1996 | WO1996011205A1 Peptide nucleic acid conjugates |
| 04/18/1996 | WO1996011021A2 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 04/18/1996 | WO1996011019A1 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 04/18/1996 | WO1996011018A1 Stable, aqueous alfa interferon solution formulations |
| 04/18/1996 | WO1996011017A1 A novel inhibitor of hepatitis b virus replication |
| 04/18/1996 | WO1996011016A1 TREATMENT OF OBSTRUCTIVE AIRWAY DISEASE BY ADMINISTERING THYMOSIN β4, OR COADMINISTRATION OF THYMOSIN β4 AND DNase I |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996011012A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | WO1996011010A1 Bridged and unbridged quadruplex/duplex oligonucleotides |
| 04/18/1996 | WO1996011004A1 Agent for treating papilloma virus-positive malignant and premalignant lesions |
| 04/18/1996 | WO1996010990A1 Two-component cream |
| 04/18/1996 | WO1996010910A1 Method and formulation of stimulating nitric oxide synthesis |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996005288A3 T cell activation |
| 04/18/1996 | DE4436772A1 Neues Dipeptid-Derivat, Verfahren zu seiner Herstellung sowie diese Verbindung enthaltende Arzneimittel New dipeptide derivative, process for its preparation and pharmaceutical compositions containing this compound |
| 04/18/1996 | DE4436352A1 Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen Method for the diagnostic assessment and monitoring and drugs for the treatment of shock in humans |
| 04/18/1996 | CA2202472A1 Hematopoietic cell l-selectin ligand (hll) and therapeutics thereof |
| 04/18/1996 | CA2202272A1 Treatment of tissues to reduce subsequent response to injury |
| 04/18/1996 | CA2202066A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | CA2201721A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | CA2201702A1 Selective inhibition of internally initiated rna translation |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0707071A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 04/17/1996 | EP0707067A2 A novel gene coding thrombin-like protease |
| 04/17/1996 | EP0707065A2 Parietaria allergens |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |
| 04/17/1996 | EP0706798A1 Pharmaceutical composition containing biologically active peptide or protein |
| 04/17/1996 | EP0706794A1 Anti-aids pharmaceutical preparations and processes for the production thereof |
| 04/17/1996 | EP0706792A1 Method of potentiating an immune response and compositions therefor |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706656A1 Immunoassay for soluble fibrin polymers |
| 04/17/1996 | EP0706581A1 Dna profiles as an indicator of cellular redox potential and cancer risk |
| 04/17/1996 | EP0706575A1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
| 04/17/1996 | EP0706573A1 Protein tyrosine kinase and ligands thereof |
| 04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
| 04/17/1996 | EP0706567A1 Peptide family, designated as xenonins |
| 04/17/1996 | EP0706566A1 Conotoxins having acetylcholin receptor binding properties |
| 04/17/1996 | EP0706564A1 Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods |
| 04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
| 04/17/1996 | EP0706533A1 Synthetic peptides of human papillomavirus |
| 04/17/1996 | EP0706532A1 New compound and its preparation |
| 04/17/1996 | EP0706528A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 04/17/1996 | EP0706525A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 04/17/1996 | EP0706400A1 Therapeutic formulation and method |
| 04/17/1996 | EP0706383A1 Compositions for inhalation |
| 04/17/1996 | EP0706382A1 Therapeutic preparation for inhalation |
| 04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
| 04/17/1996 | EP0638091A4 Improved solubilization and stabilization of factor viii complex. |
| 04/17/1996 | EP0618815B1 Monoclonal antibodies against type i phospholipase a 2?, used as a therapeutic agent to reduce inflammation |
| 04/17/1996 | EP0568594B1 NOVEL INSULIN ANALOGS suited for transdermal application |
| 04/17/1996 | EP0558673B1 Retroviral protease inhibitors |
| 04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
| 04/17/1996 | EP0493468B1 Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 04/17/1996 | EP0436660B1 Peptides and antibodies that inhibit integrin-ligand binding |
| 04/17/1996 | EP0429534B1 Molecular conjugates containing cell membrane-blending agents |
| 04/17/1996 | EP0428596B1 Novel infectious bursal disease virus |
| 04/17/1996 | CN1120852A Needleless syringe using supersonic gas flow for particle delivery |
| 04/17/1996 | CN1120846A Metal-interferon-alpha crystals |
| 04/17/1996 | CN1120845A 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
| 04/17/1996 | CN1120844A Phosphonomethyldipeptides |
| 04/17/1996 | CN1120843A 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 04/17/1996 | CN1120803A Method and apparatus for treating a body fluid |
| 04/17/1996 | CN1120549A Calcitonin analogue and use thereof |
| 04/17/1996 | CN1120548A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them |
| 04/17/1996 | CN1120547A Method for prepn. of NTPS |
| 04/17/1996 | CN1120458A Physiologically active peptide compositions |
| 04/17/1996 | CN1120457A Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| 04/17/1996 | CN1120456A "Cunaokang" medicine for promoting brain health |
| 04/17/1996 | CN1120439A Low temperature albumin fractionation using sodium caprylates as a partitioning agent |
| 04/16/1996 | US5508437 Appetite suppressants |
| 04/16/1996 | US5508407 Treating or preventing infection by hiv |
| 04/16/1996 | US5508387 Selectin binding glycopeptides |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508385 Protease inhibitor; antiulcer agents, antiinflammatory agents; treating pancreatitis |
| 04/16/1996 | US5508384 Polypeptide derived from a popamine receptor, and compositions and methods thereof |
| 04/16/1996 | US5508383 Cyclic peptide LHRH antagonists |
| 04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
| 04/16/1996 | US5508272 Compounds containing a fused bicycle ring and processes therefor |
| 04/16/1996 | US5508266 Useful as angiotensin converting enzyme inhibitors and neutral endopeptidase inhibitors; administering to treat cardiovascular disorders |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
| 04/16/1996 | US5508262 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
| 04/16/1996 | US5508260 Mixtures of insulin and calcitonin which can promote uniform blood glucose concentration |
| 04/16/1996 | US5508045 Administering nitric oxide donor |
| 04/16/1996 | US5508031 Method for treating biological damage using a free-radial scavenger and interleukin-2 |